Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
China
· Delayed Price · Currency is CNY 7.69
-0.13 (-1.66%)
Apr 25, 2025, 2:45 PM CST
Guangdong VTR Bio-Tech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 17.19 | 31.95 | -10.75 | 18.23 | -118.91 | 161.71 | Upgrade
|
| Depreciation & Amortization | 113.27 | 113.27 | 110.83 | 138.27 | 167.86 | 155.32 | Upgrade
|
| Other Amortization | 3.67 | 3.67 | 7.47 | 4.61 | 9.03 | 2.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | -3.01 | -3.01 | -0.05 | 0.06 | 0.23 | -0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.12 | 2.12 | 12.95 | 0.43 | 82.47 | 1.71 | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.84 | -2.84 | -5.38 | -156.82 | 2.28 | -9.43 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -16.78 | -0.17 | 34.95 | 14.36 | Upgrade
|
| Other Operating Activities | -54.76 | 8.23 | 24.46 | 54.6 | 115.84 | 100.09 | Upgrade
|
| Change in Accounts Receivable | -25.38 | -25.38 | 27.66 | 154.07 | 11.84 | 11.92 | Upgrade
|
| Change in Inventory | -2.6 | -2.6 | 13.39 | -28.43 | 13.84 | 14.24 | Upgrade
|
| Change in Accounts Payable | -51.76 | -51.76 | -5.88 | 57.23 | -82.71 | -47.34 | Upgrade
|
| Operating Cash Flow | -8.55 | 69.19 | 154.4 | 249.77 | 216.93 | 403.73 | Upgrade
|
| Operating Cash Flow Growth | - | -55.19% | -38.18% | 15.14% | -46.27% | -8.69% | Upgrade
|
| Capital Expenditures | -352.15 | -377.4 | -394.17 | -197.78 | -162.98 | -283.04 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.55 | 0.79 | 0.22 | 0.02 | 0.02 | 0.04 | Upgrade
|
| Cash Acquisitions | 70.9 | -9.1 | - | -4.06 | -91.15 | -11.8 | Upgrade
|
| Divestitures | - | - | - | 1,201 | - | -2.24 | Upgrade
|
| Investment in Securities | 227 | 147 | 123 | -1,432 | -0.62 | -14.33 | Upgrade
|
| Other Investing Activities | 155.7 | 157.75 | 413.16 | 21.91 | 0.19 | 0.01 | Upgrade
|
| Investing Cash Flow | 102 | -80.95 | 142.22 | -411.31 | -254.53 | -311.37 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 5 | Upgrade
|
| Long-Term Debt Issued | - | 35 | 89.35 | 429.9 | 901.5 | 843.26 | Upgrade
|
| Total Debt Issued | 35 | 35 | 89.35 | 429.9 | 901.5 | 848.26 | Upgrade
|
| Long-Term Debt Repaid | - | -49.83 | -115 | -710.28 | -825.39 | -885.3 | Upgrade
|
| Net Debt Issued (Repaid) | 29.17 | -14.83 | -25.65 | -280.38 | 76.11 | -37.04 | Upgrade
|
| Issuance of Common Stock | - | - | 0.95 | - | - | 98 | Upgrade
|
| Common Dividends Paid | -34.55 | -34.55 | -51.06 | -61.94 | -69.98 | -63.7 | Upgrade
|
| Other Financing Activities | -92.59 | 92.43 | -138.49 | 419.19 | 30.49 | -2.05 | Upgrade
|
| Financing Cash Flow | -97.98 | 43.05 | -214.25 | 76.87 | 36.62 | -4.8 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.21 | -2.62 | 0.6 | 2.08 | -0.33 | 0.55 | Upgrade
|
| Net Cash Flow | -3.33 | 28.67 | 82.97 | -82.58 | -1.31 | 88.11 | Upgrade
|
| Free Cash Flow | -360.7 | -308.2 | -239.77 | 51.99 | 53.95 | 120.68 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -3.64% | -55.29% | 172.69% | Upgrade
|
| Free Cash Flow Margin | -43.47% | -37.30% | -30.12% | 4.43% | 2.85% | 6.30% | Upgrade
|
| Free Cash Flow Per Share | -0.73 | -0.63 | -0.49 | 0.11 | 0.11 | 0.26 | Upgrade
|
| Cash Income Tax Paid | 35.19 | 35.63 | 31.9 | 87.51 | 89.61 | 28.99 | Upgrade
|
| Levered Free Cash Flow | -276.76 | -245.79 | -241.03 | 778.97 | 70.6 | -16.1 | Upgrade
|
| Unlevered Free Cash Flow | -276.76 | -245.79 | -239.26 | 791.32 | 92.11 | 13 | Upgrade
|
| Change in Net Working Capital | 49.71 | -4.22 | -51.53 | -896.2 | -55.61 | 10.22 | Upgrade
|
Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.